FWL INVESTMENT MANAGEMENT, LLC

Position in AKTS — Aktis Oncology, Inc.

CIK 1829231 Dallas, TX

Position in AKTS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$741

New position

Shares Held

23

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#106

of 113 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FWL INVESTMENT MANAGEMENT, LLC holds $34,514 across 4 Biotechnology names. AKTS ranks #3 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	333	$18,671
2	VRTX	Vertex Pharmaceuticals Inc / Ma	30	$14,901
3	AKTS	Aktis Oncology, Inc. This page	23	$741
4	RXRX	Recursion Pharmaceuticals, Inc.	55	$201

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$741	23	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.